MDx Testing Moves Closer to Patients as Labs Lose Their Central Role
The COVID-19 pandemic brought innovation and investment to the in vitro diagnostics (IVD) market, opening new pathways to simplify and expand testing. The previously complicated and time-consuming molecular testing gradually...